Ftse Mib
34.650,95
0,91%
DAX
18.772,85
0,50%
S&P 500
5.222,68
0,16%
NASDAQ
16.340,87
-0,03%
Bitcoin
60.534,71
-3,99%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Aptinyx Inc (APTX) Aptinyx Inc (APTX) Notizie

APTX

Aptinyx (APTX)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:APTX
DataOraFonteTitoloSimboloCompagnia
21/12/202316:52Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APTXAptinyx Inc
27/06/202320:14Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:APTXAptinyx Inc
24/05/202322:50Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:APTXAptinyx Inc
24/05/202322:44Edgar (US Regulatory)Withdrawal of Registration Statement (rw)NASDAQ:APTXAptinyx Inc
23/05/202314:26Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:APTXAptinyx Inc
15/05/202322:46Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:APTXAptinyx Inc
11/05/202314:02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:APTXAptinyx Inc
28/04/202322:19Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:APTXAptinyx Inc
30/03/202322:31Edgar (US Regulatory)Annual Report (10-k)NASDAQ:APTXAptinyx Inc
30/03/202322:05Business WireAptinyx Reports on Fourth Quarter and Full Year 2022 Results and Highlights and Review of Strategic AlternativesNASDAQ:APTXAptinyx Inc
27/02/202322:03Business WireAptinyx Reports Results from Phase 2 Study of NYX-458 in Cognitive Impairment Associated with Parkinson's Disease and Dementia with Lewy Bodies and Provides Pipeline and Corporate UpdateNASDAQ:APTXAptinyx Inc
31/01/202313:47Business WireAptinyx to Present at the SVB Securities Global Biopharma ConferenceNASDAQ:APTXAptinyx Inc
05/01/202322:18Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:APTXAptinyx Inc
12/12/202212:25TipRanksH.C. Wainwright Keeps Their Buy Rating on Aptinyx (APTX)NASDAQ:APTXAptinyx Inc
10/11/202213:45Business WirePreclinical Data from Aptinyx’s NMDA Receptor Modulators to be Presented at the 52nd Annual Meeting of the Society for NeuroscienceNASDAQ:APTXAptinyx Inc
10/11/202205:26TipRanksSVB Securities Keeps Their Buy Rating on Aptinyx (APTX)NASDAQ:APTXAptinyx Inc
09/11/202216:16TipRanksBMO Capital Remains a Buy on Aptinyx (APTX)NASDAQ:APTXAptinyx Inc
08/11/202222:32Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:APTXAptinyx Inc
08/11/202222:05Business WireAptinyx Reports Third Quarter 2022 Financial Results and Recent HighlightsNASDAQ:APTXAptinyx Inc
03/11/202212:30Business WireClinical Evaluation of Aptinyx's NYX-783 for Treatment of Opioid Use Disorder to Be Funded by $5.6 Million NIH GrantNASDAQ:APTXAptinyx Inc
18/10/202213:45Business WireAptinyx to Report Third Quarter 2022 Financial Results on Tuesday, November 8, 2022NASDAQ:APTXAptinyx Inc
25/08/202213:30Business WireAptinyx Completes Enrollment in Phase 2 Study of NYX-458 in Cognitive Impairment Associated with Parkinson’s Disease and Dementia with Lewy BodiesNASDAQ:APTXAptinyx Inc
12/08/202213:15Business WireAptinyx Reports Results from Phase 2b Study of NYX-2925 in FibromyalgiaNASDAQ:APTXAptinyx Inc
05/08/202214:38TipRanksBMO Capital Sticks to Its Buy Rating for Aptinyx (APTX)NASDAQ:APTXAptinyx Inc
04/08/202222:05Business WireAptinyx Reports Second Quarter 2022 Financial Results and Recent HighlightsNASDAQ:APTXAptinyx Inc
03/08/202204:35TipRanksSVB Securities Maintains a Buy Rating on Aptinyx (APTX)NASDAQ:APTXAptinyx Inc
15/07/202213:47Business WireAptinyx to Report Second Quarter 2022 Financial Results on Thursday, August 4, 2022NASDAQ:APTXAptinyx Inc
24/06/202220:33Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:APTXAptinyx Inc
22/06/202213:47Business WireAptinyx to Participate in H.C. Wainwright 1st Annual Mental Health ConferenceNASDAQ:APTXAptinyx Inc
23/05/202212:29TipRanksH.C. Wainwright Thinks Aptinyx’s Stock is Going to RecoverNASDAQ:APTXAptinyx Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:APTX

La tua Cronologia

NYSE
ASL
Ashanti Goldfields
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network